FSB Premier Wealth Management’s GSK GSK Stock Holding History

FSB Premier Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$246K	Sell	4,461 -357	-7%	-$19.3K	0.08%	224
2025 Q4	$236K	Sell	4,818 -122	-2%	-$5.69K	0.08%	214
2025 Q3	$213K	Buy	+4,940	New	+$193K	0.07%	219
2022 Q1	–	Sell	-436	Closed	-$24K	–	315
2021 Q4	$24K	Buy	+436	New	+$22.7K	0.01%	324

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FSB Premier Wealth Management's GSK Position: Q1 2026 in Review

FSB Premier Wealth Management reduced its GSK (GSK) stake by 7.4% in Q1 2026, selling an estimated $19.3K and leaving 4,461 shares worth $246K. The position accounts for 0.08% of the portfolio, ranked #224.

FSB Premier Wealth Management first reported a position in GSK in Q4 2021 and has held it in 4 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

FSB Premier Wealth Management held 4,461 shares of GSK worth $246K as of Q1 2026.
FSB Premier Wealth Management sold 357 GSK shares in Q1 2026, an estimated $19.3K.
GSK made up 0.08% of FSB Premier Wealth Management's portfolio in Q1 2026, its #224 holding.
FSB Premier Wealth Management first reported a position in GSK in Q4 2021 and has held it in 4 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on FSB Premier Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.